A recent study conducted by researchers from Johns Hopkins University School of Medicine has raised concerns about the limited access to powerful weight loss medications for those who need them most. The study, presented by Dr. Chiadi Ndumele at an American Heart Association meeting in Chicago, looked at the health records of 18,000 patients with obesity who had insurance coverage for weight loss drugs. Shockingly, only 2.3% of these patients were actually prescribed the medications.
The study identified several barriers that prevent individuals from obtaining weight loss medications, including difficulty in obtaining a prescription, finding pharmacies that have the medications in stock, and being able to afford them. Factors such as high copays, prior authorization requirements, and discomfort in discussing obesity with patients were also found to contribute to the low prescription rates.
Furthermore, the study revealed disparities in prescription rates, with white adults more likely to receive a prescription compared to Asian and Black adults. Patients with a higher body mass index (BMI), hypertension, or Type 2 diabetes were also more likely to be prescribed weight loss medications.
Experts believe that more physicians need to be trained in obesity medicine in order to address the issue of limited access to weight loss medications. They also suggest that in-office conversations and medication shortages may be additional factors impacting prescription rates.
Overall, the study highlights the urgent need to improve access to weight loss medications for individuals struggling with obesity. Addressing the barriers identified in the study could help more patients receive the necessary treatment to reach their weight loss goals and improve their overall health.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”